A Study of Belantamab Mafodotin in Patients With Relapsed or Refractory AL Amyloidosis
Clinical trial NCT04617925 · COMPLETED
Trial details
- NCT number
- NCT04617925
- Sponsor
- Stichting European Myeloma Network
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-26
- Primary completion
- 2025-07-17
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.